https://orcid.org/0000-0002-0458-044X
References
- Perez J, Garrigós L, Gion M, et al. Trastuzumab deruxtecan in HER2-positive metastatic breast cancer and beyond. Expert Opin Biol Ther. 2021 Jul;21(7):811–824.
- Morris CR, Hurst EA. Extramammary Paget’s disease: a review of the literature part II: treatment and prognosis. Dermatol Surg. 2020 Mar;46(3):305–311.
- Tanaka R, Sasajima Y, Tsuda H, et al. Human epidermal growth factor receptor 2 protein overexpression and gene amplification in extramammary Paget disease. Br J Dermatol. 2013 Jun;168(6):1259–1266.
- Lu X, Zhang P, Zhu Y, et al. Human epidermal growth factor receptor 2 amplification as a biomarker for treatment in patients with lymph node-metastatic penoscrotal extramammary Paget’s disease. Oncol Lett. 2019 Mar;17(3):2677–2686.
- Ichiyama T, Gomi D, Fukushima T, et al. Successful and long-term response to trastuzumab plus paclitaxel combination therapy in human epidermal growth factor receptor 2-positive extramammary Paget’s disease: a case report and review of the literature. Mol Clin Oncol. 2017 Nov;7(5):763–766.
- Zhang X, Jin W, Zhu H, et al. Extramammary Paget’s disease in two brothers. Indian J Dermatol. 2015 Jul-Aug;60(4):423.
- Angelico G, Santoro A, Inzani F, et al. Hormonal environment and HER2 status in Extra-Mammary Paget’s Disease (eMPD): a systematic literature review and meta-analysis with clinical considerations. Diagnostics (Basel). 2020 Dec 3;10(12):1040.
- Takahagi S, Noda H, Kamegashira A, et al. Metastatic extramammary Paget’s disease treated with paclitaxel and trastuzumab combination chemotherapy. J Dermatol. 2009 Aug;36(8):457–461.
- Hanawa F, Inozume T, Harada K, et al. A case of metastatic extramammary Paget’s disease responding to trastuzumab plus paclitaxel combination therapy. Case Rep Dermatol. 2011 Sep;3(3):223–227.
- Wakabayashi S, Togawa Y, Yoneyama K, et al. Dramatic clinical response of relapsed metastatic extramammary Paget’s disease to trastuzumab monotherapy. Case Rep Dermatol Med. 2012;2012:401362.
- Barth P, Dulaimi Al-Saleem E, Edwards KW, et al. Metastatic extramammary Paget’s disease of scrotum responds completely to single agent trastuzumab in a hemodialysis patient: case report, molecular profiling and brief review of the literature. Case Rep Oncol Med. 2015;2015:895151.
- Maeda T, Kitamura S, Nishihara H, et al. Extramammary Paget’s disease patient-derived xenografts harboring ERBB2 S310F mutation show sensitivity to HER2-targeted therapies. Oncogene. 2020 Sep;39(36):5867–5875.
- Masuguchi S, Jinnin M, Fukushima S, et al. The expression of HER-2 in extramammary Paget’s disease. Biosci Trends. 2011 Aug;5(4):151–155.
- Tanaka R, Sasajima Y, Tsuda H, et al. Concordance of the HER2 protein and gene status between primary and corresponding lymph node metastatic sites of extramammary Paget disease. Clin Exp Metastasis. 2016 Oct;33(7):687–697.